Inhibrx: Ozekibart Beyond Chondrosarcoma, With Other Targeted Indications, Too

Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.

What Canadian airlines are saying after study claims water on many U.S. flights 'potentially unhealthy'

Passengers can be at ease while travelling on Canadian carriers, some of the country’s major airlines say, after a new study ...
Belfast Live

Eating this 16p food every day could help reduce risk of 'silent killer'

Hypertension is one of the most common forms of heart disease in the United Kingdom, with millions of British people dealing ...

Sleep patterns could predict risk for dementia, cancer and stroke, study suggests

A Stanford AI model trained on nearly 600,000 hours of sleep data can assess future risk for dementia, heart disease and more ...
Sunderland Echo

Twenty-nine per cent of Sunderland AFC fans still smoke daily, according to study

A new survey from Haypp challenges stereotypes about Premier League football fans, showing patterns of exercise, alcohol ...